Hypertension in pregnancy: natural history and treatment options (Q38400715)

2 September 2017

1 reference

title

Hypertension in pregnancy: natural history and treatment options (English)

1 reference

2 September 2017

0 references

L Foo

1

1 reference

2 September 2017

J Tay

2

1 reference

2 September 2017

C C Lees

3

1 reference

2 September 2017

C M McEniery

4

1 reference

2 September 2017

I B Wilkinson

5

1 reference

2 September 2017

1 May 2015

1 reference

Current Hypertension Reports

2 September 2017

1 reference

2 September 2017

17

1 reference

2 September 2017

5

1 reference

2 September 2017

36

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-015-0545-1

2 September 2017

0 references

cites work

Global causes of maternal death: a WHO systematic analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

ASH position paper: hypertension in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Hypertensive disease of pregnancy and maternal mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Maternal death from stroke: a thirty year national retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Temporal relationships between hormonal and hemodynamic changes in early human pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Maternal cardiovascular changes from pre-pregnancy to very early pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Pregnancy as a cardiac stress model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Hypertension in pregnancy and women of childbearing age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Volume homeostasis in normal pregnancy and pre-eclampsia: physiology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

A Comprehensive Review of Hypertension in Pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

A molecular variant of angiotensinogen associated with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Ambulatory blood pressure monitoring in pregnancy: what is normal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Untoward effects of rapid-acting antihypertensive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Placental origins of preeclampsia: challenging the current hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Circulating angiogenic factors and the risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Impact of preeclampsia and gestational hypertension on birth weight by gestational age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

The "Great Obstetrical Syndromes" are associated with disorders of deep placentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

A role for Notch signaling in trophoblast endovascular invasion and in the pathogenesis of pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Distribution of Notch family proteins in intrauterine growth restriction and hypertension complicated human term placentas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Learning from the placenta: acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Review: Preeclampsia, acute atherosis of the spiral arteries and future cardiovascular disease: two new hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Preeclampsia: the role of angiogenic factors in its pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Molecular mechanisms of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

The role of nitric oxide in the altered vascular reactivity of pregnancy in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Nitric oxide: an endogenous modulator of leukocyte adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Maternal cardiovascular impairment in pregnancies complicated by severe fetal growth restriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Severely impaired fetal growth is preceded by maternal hemodynamic maladaptation in very early pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Beyond the placental bed: placental and systemic determinants of the uterine artery Doppler waveform

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Uterine artery Doppler, birth weight and timing of onset of pre-eclampsia: providing insights into the dual etiology of late-onset pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Effect of uncomplicated chronic hypertension on the risk of small-for-gestational age birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Predictive value of clinical and laboratory indices at first assessment in women referred with suspected gestational hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Maternal blood pressure in pregnancy, birth weight, and perinatal mortality in first births: prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Drug treatment of hypertension in pregnancy: a critical review of adult guideline recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Hypertension during pregnancy, with and without specific hypotensive treatment. II. The growth and development of the infant in the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Is clonidine a behavioural teratogen in the human?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Atenolol in essential hypertension during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Effect of atenolol on birth weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

The risk of congenital malformations associated with exposure to β-blockers early in pregnancy: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

The risk of limb deficiencies and other congenital abnormalities in children exposed in utero to calcium channel blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Digital defects induced by vasodilating agents: relationship to reduction in uteroplacental blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Calcium channel blockers in the management of preterm labor and hypertension in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Antihypertensive drugs and the risk of congenital anomalies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Major congenital malformations after first-trimester exposure to ACE inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Angiotensin II receptor antagonist treatment during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Hemodynamic collapse following labetalol administration in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Vitamins C and E and the risks of preeclampsia and perinatal complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Combined vitamin C and E supplementation for the prevention of preeclampsia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Is vitamin E a safe prophylaxis for preeclampsia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Efficacy of nitroglycerine infusion versus sublingual nifedipine in severe pre-eclampsia: a randomized, triple-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

The effect of glyceryl trinitrate on hypertension in women with severe preeclampsia, HELLP syndrome, and eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

The efficacy and fetal-maternal cardiovascular effects of transdermal glyceryl trinitrate in the prophylaxis of pre-eclampsia and its complications: a randomized double-blind placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

S-Nitrosoglutathione improves haemodynamics in early-onset pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

L-arginine infusion reduces blood pressure in preeclamptic women through nitric oxide release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

The therapeutic potential of antioxidants, ER chaperones, NO and H2S donors, and statins for treatment of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Effects of pravastatin on mediators of vascular function in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

A new mouse model to explore therapies for preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Transfer of labetalol into amniotic fluid and breast milk in lactating women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Postpartum management of hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Cardiovascular disease risk factors in women with a history of early-onset preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Preeclampsia is associated with persistent postpartum cardiovascular impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Cardiovascular sequelae of toxaemia of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Prescribing exercise for women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Recreational physical activity and the risk of preeclampsia: a prospective cohort of Norwegian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

The effect of leisure time physical activity on the risk of pre-eclampsia and gestational hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Work, leisure-time physical activity, and risk of preeclampsia and gestational hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Does physical activity in leisure time early in pregnancy reduce the incidence of preeclampsia or gestational hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0545-1

ACOG practice bulletin on diagnosing and managing preeclampsia and eclampsia. American College of Obstetricians and Gynecologists

21 January 2018

1 reference

12 December 2020

Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom

1 reference

12 December 2020

Individualized risk assessment for adverse pregnancy outcome by uterine artery Doppler at 23 weeks

1 reference

12 December 2020

Cardiovascular alterations in rat fetuses exposed to calcium channel blockers

1 reference

12 December 2020

Maternal hemodynamics at 11-13 weeks' gestation and risk of pre-eclampsia

1 reference

12 December 2020

Unexpected results of an important trial of vitamins C and E administration to prevent preeclampsia

1 reference

12 December 2020

Central aortic blood pressure and augmentation index during normal pregnancy

1 reference

12 December 2020

Spironolactone therapy during human pregnancy

1 reference

12 December 2020

Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone

1 reference

12 December 2020

Placental ischaemia is a consequence rather than a cause of pre-eclampsia

1 reference

12 December 2020

Neonatal anuria with maternal angiotensin-converting enzyme inhibition

1 reference

12 December 2020

Structural and functional changes in left ventricle during normotensive and preeclamptic pregnancy

1 reference

12 December 2020

Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia

1 reference

12 December 2020

Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial

1 reference

12 December 2020

Hydralazine boluses for the treatment of severe hypertension in pre-eclampsia

1 reference

12 December 2020

Influence of hypertensive disorders and cigarette smoking on placental abruption and uterine bleeding during pregnancy.

1 reference

12 December 2020

Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births

1 reference

12 December 2020

The ultrastructure of the arterial supply of the human placenta in pregnancy complicated by fetal growth retardation

1 reference

12 December 2020

Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

The excretion of enalapril and enalaprilat in human breast milk

1 reference

12 December 2020

Cardiovascular changes in preeclampsia

1 reference

12 December 2020

Treatment of HELLP syndrome with nitric oxide donor

1 reference

12 December 2020

Distribution of Notch protein members in normal and preeclampsia-complicated placentas

1 reference

12 December 2020

Recurrence risk of preeclampsia in twin and singleton pregnancies

1 reference

12 December 2020

The circulatory effects of recumbent postural change in late pregnancy

1 reference

12 December 2020

Changes observed in Doppler studies of the fetal circulation in pregnancies complicated by pre-eclampsia or the delivery of a small-for-gestational-age baby. I. Cross-sectional analysis

1 reference

12 December 2020

ACOG Committee opinion. Number 267, January 2002: exercise during pregnancy and the postpartum period

1 reference

12 December 2020

Endothelial cell activation as a pathogenetic factor in preeclampsia

1 reference

12 December 2020

Magnesium plus nifedipine

1 reference

12 December 2020

Pregnancy-induced hypertension: recurrence rate in second pregnancies

1 reference

12 December 2020

Blood pressure survey in pregnancy

1 reference

12 December 2020

Haemodynamic changes during the puerperium: a Doppler and M-mode echocardiographic study

1 reference

12 December 2020

Differences between office and 24-hour ambulatory blood pressure measurement during pregnancy

1 reference

12 December 2020

Chronic hypertension and risk of placental abruption: is the association modified by ischemic placental disease?

1 reference

12 December 2020

Antiplatelet agents for preventing pre-eclampsia and its complications

1 reference

12 December 2020

The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade

1 reference

12 December 2020

Antihypertensive therapy in pregnancy

1 reference

12 December 2020

Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy

1 reference

12 December 2020

Impact of the nitric oxide-donor pentaerythrityl-tetranitrate on perinatal outcome in risk pregnancies: a prospective, randomized, double-blinded trial

1 reference

12 December 2020

A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of pre-eclampsia

1 reference

12 December 2020

Gestational changes in endothelium-dependent vasorelaxation in human umbilical artery

1 reference

12 December 2020

[Progression of gestational hypertension to preeclampsia]

1 reference

12 December 2020

Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks

1 reference

12 December 2020

Higher risk of pre-eclampsia after change of partner. An effect of longer interpregnancy intervals?

1 reference

12 December 2020

Early and Late Preeclampsia

1 reference

12 December 2020

The effects of S-nitrosoglutathione on platelet activation, hypertension, and uterine and fetal Doppler in severe preeclampsia

1 reference

12 December 2020

A longitudinal study of maternal cardiovascular function from preconception to the postpartum period

1 reference

12 December 2020

Drugs for treatment of very high blood pressure during pregnancy

1 reference

12 December 2020

1 reference

12 December 2020

Labetalol vs. methyldopa in the treatment of pregnancy-induced hypertension

1 reference

12 December 2020

Fetal distress after hydralazine therapy for severe pregnancy-induced hypertension.

1 reference

12 December 2020

Prolonged use of methyldopa in severe hypertension in pregnancy

1 reference

12 December 2020

One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation

1 reference

12 December 2020

10.1007/S11906-015-0545-1

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference